Patheon Biologics CDMO Corporate Presentation December 2023

Leading independent biologics CDMO offering comprehensive services from cell line development through commercial manufacturing. Company highlights experienced management, recent facility expansions in mammalian and cell/gene therapy capabilities, and a strong regulatory track record serving a growing biopharmaceutical pipeline.